Skip to main content
. 2021 Sep 6;40:281. doi: 10.1186/s13046-021-02056-9

Fig. 2.

Fig. 2

Behavior of markers of disease burden (ALP and PSA) and haematopoietic impairment (HB, PLT, RBC, WBC) before of each 223Ra administration. Values are reported as symbols, while lines are used only to connect all the patient values. Numbers indicate the enrolled patients